S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ELOX Eloxx Pharmaceuticals Inc

3.82

0.00 (0.00%)

14 Feb 2025 - Closed

Delayed by 15 minutes

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals Inc News

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 21 August 2024 (6 months ago) • Edgar (US Regulatory)

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Friday 12 July 2024 (7 months ago) • GlobeNewswire Inc.

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
Tuesday 16 April 2024 (10 months ago) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Tuesday 2 April 2024 (11 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 30 March 2024 (11 months ago) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Friday 22 March 2024 (11 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 March 2024 (11 months ago) • Edgar (US Regulatory)

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
Thursday 14 March 2024 (11 months ago) • GlobeNewswire Inc.

More Eloxx Pharmaceuticals Inc News Articles

Westpac Banking

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions